Skip to main content

Table 1 Clinical data of the ESFT patients included in array CGH and/or data integration analysis.

From: Combined use of expression and CGH arrays pinpoints novel candidate genes in Ewing sarcoma family of tumors

Code

Included in data integration analysis

Diagnosis

Origin

of sample

Chemotherapy or radiation before sample collection

Material from

Necrosis

Patient Status at Diagnosis

Age

Sex

Location

Outcome

EFS

EFS months

Outcome

OVS

OVS months

Type of Translocation

D150

X

Ewing

PRI

no

Biopsy

 

Localized

23

M

Femur

REL

6

DEAD

12

EWS/FLI-1

type 2

D152

X

Ewing

PRI

no

Biopsy

 

Pri Met Lung

15

M

Pelvis

REL

8

DEAD

17

EWS/FLI-1

type 2

D153

X

Ewing

PRI

no

Biopsy

 

Pri Met Bone

22

M

Pelvis

REL

0

DEAD

5

EWS/FLI-1

type 3

D154

X

Ewing

PRI

yes

Resection

50%

Localized

19

M

Humerus

REL

19

AWD

57

Neg/Neg

D155

 

Ewing

PRI

no

Biopsy

 

Localized

15

F

Pelvis

NED

69

NED

69

EWS/FLI-1

type 1

D162

 

Ewing

PRI

yes

Resection

90%

Localized

20

M

Tibia

NED

61

NED

61

Neg/Neg

D239

 

Ewing

PRI

yes

Resection

95%

Localized

21

F

Scapula

REL

34

NED

41

EWS/FLI-1

type 2

D240

 

Ewing

PRI

yes

Resection

30%

Pri Met Lung

10

F

Humerus

REL

13

DEAD

15

EWS/FLI-1

type 1

D241

 

Ewing

PRI

yes

Resection

> 95%

Localized

28

M

Femur

NED

47

NED

47

EWS/FLI-1

type 2

D245

 

Ewing

PRI

yes

Resection

70%

Localized

22

M

Radius

REL

4

DEAD

8

NA

D248

 

Ewing

PRI

yes

Resection

95%

Localized

11

M

Scapula

NED

76

NED

76

EWS/FLI-1

type 1

D250

 

Ewing

PRI

yes

Resection

75%

Pri Met Lung

32

F

Clavicula

REL

20

DEAD

31

Neg/Neg

D311

X

Ewing

PRI

no

Biopsy

 

Localized

13

M

Pelvis

NED

43

NED

43

EWS/FLI-1

type 1

D313

X

Ewing

PRI

no

Biopsy

 

Localized

24

M

Femur

REL

18

NED

117

EWS/FLI-1

type 1

D316

X

Ewing

PRI

yes

Resection

60%

Pri Met Lung

11

M

Femur

REL

10

DEAD

10

EWS/FLI-1

type 1

D320

X

Ewing

PRI

no

Biopsy

 

Localized

5

M

Humerus

REL

14

DEAD

21

EWS/FLI-1

type 2

D322

X

Ewing

PRI

yes

Resection

25%

Localized

27

F

Femur

REL

29

NED

67

EWS/FLI-1

type 1

D242

 

Ewing Extr

PRI

no

Biopsy

 

Localized

41

F

Thorax

NED

56

NED

56

NA

D246

 

Ewing Extr

PRI

no

Biopsy

 

Localized

26

F

Thigh

NED

49

NED

49

EWS/FLI-1

type 1

D249

 

Ewing Extr

PRI

no

Biopsy

 

Localized

35

M

Thigh

REL

7

AWD

13

NA

D252

 

Ewing Extr

PRI

no

Biopsy

 

Pri Met Lung

18

M

Thigh

REL

0

DEAD

13

EWS/FLI-1

type 1

D253

 

Askin's

PRI

yes

Resection

10%

Localized

24

M

Rib

REL

5

DEAD

12

EWS/FLI-1

type 2

D254

 

Askin's

PRI

yes

Resection

15%

Pri Met Lung

21

M

Rib

NA

NA

NA

NA

NA

D156

 

Askin's

REC

no

Resection

 

Localized

15

M

Rib

REL

17

DEAD

21

EWS/FLI-1

type 1

D157

X

Ewing

REC

no

Amputation

 

Pri Met Lung

30

F

Femur

REL

3

DEAD

25

EWS/FLI-1

type 1

D255

X

Ewing

LUNG MET

no

Resection

 

Pri Met Lung

17

M

Scapula

REL

31

DEAD

43

EWS/FLI-1

type 1

D256

X

Ewing

LUNG MET

no

Resection

 

Localized

34

M

Humerus

REL

17

NED

136

EWS/FLI-1

type 1

D312

X

Ewing

LUNG MET

no

Resection

 

Localized

9

M

Fibula

REL

28

DEAD

42

EWS/FLI-1

type 1

D321

X

Ewing

LUNG MET

no

Lobectomy

 

Localized

24

M

Pelvis

REL

34

DEAD

80

EWS/FLI-1

type 1

D315

X

PNET

BONE MET

no

Biopsy

 

Localized

16

M

Tibia

REL

58

DEAD

99

EWS/FLI-1

type 1

D257

X

PNET

BONE MET

no

Biopsy

 

Localized

16

F

Femur

REL

6

DEAD

8

EWS/FLI-1

type 2

  1. Extr = extraskeletal; PRI = primary tumor; REC = local recurrence; MET L = metastasis in lung; MET B = metastasis in bone; EFS = event-free survival; REL = relapsed; NED = no evidence of disease; NA = not available; OVS = overall survival; AWD = alive with disease.